- Nachrichtendetail
-
25.06.2024 14:17:59 - dpa-AFX: *ABBVIE RECEIVES FDA COMPLETE RESPONSE LETTER FOR ABBV-951 IN PARKINSON'S DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 159,040 | 01.07.24 10:11:59 | +0,520 | +0,33% | 158,700 | 159,480 | 159,320 | 158,520 |
